If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
335.00    -2.20 (-0.65%)
Bid:
335.90
Ask:
336.00
Spread: 0.10 (0.03%)
Market Cap: £7.35b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Directorate Change

5 Jul 2022 07:00

RNS Number : 2855R
Sainsbury(J) PLC
05 July 2022
 

J Sainsbury PLC Directorate Change

 

Kevin O'Byrne to retire from his role as Chief Financial Officer

Bláthnaid Bergin appointed Chief Financial Officer from March 2023

 

After six years as Chief Financial Officer (CFO), Kevin O'Byrne has confirmed his intention to retire from Sainsbury's at the end of this financial year, in March 2023.

 

Following a thorough external and internal search to identify a successor, the Board is pleased to appoint Bláthnaid Bergin, Commercial and Retail Finance Director, as Kevin's successor. Bláthnaid will start as Chief Financial Officer and join the PLC board on 6th March 2023.

 

Kevin joined Sainsbury's in January 2017 and, as a member of the PLC and Operating Board, has played an instrumental role in developing and implementing our strategy, in particular increasing free cash flow generation, strengthening the balance sheet and reducing leverage.

 

Bláthnaid joined Sainsbury's in 2019 as Group Director of Finance before moving to Commercial and Retail Finance Director in 2021. Bláthnaid has a strong record of financial leadership and, over the last three years at Sainsbury's, has supported the development and delivery of our strategy. Prior to joining Sainsbury's, Bláthnaid was Chief Finance Operations Officer at Aviva. She was also Group Financial Controller for RSA Insurance as well as Joint Interim Group Chief Financial Officer for six months. She is a qualified Chartered Accountant and spent most of her career at GE in various finance roles working across Europe, Asia and Australia. Bláthnaid is also a Non-Executive Director, Chair of the Audit Committee and Senior Independent Director for Artemis Alpha Investment Trust.

 

Martin Scicluna, Chairman, said:

"Kevin has made an impressive and sustained contribution both as CFO and as a Board Member to Sainsbury's performance. On behalf of the Board I would like to thank him for his continued contribution and, when the time comes, wish him well for the future.

 

"Bláthnaid' s appointment concludes an extensive CFO search process. I am delighted that our internal candidate was the strongest, with proven financial leadership.

 

"I look forward to welcoming Bláthnaid to the Board next year. I am certain that she will contribute strongly to the continued delivery of our strategy."

 

Simon Roberts, Chief Executive Officer said:

"Kevin and I have worked closely since I joined the business in 2017. He has been a great business partner, making a strong contribution. On behalf of all of Sainsbury's colleagues I would like to thank him for all he has done.

 

"Bláthnaid is well embedded in our business and is a highly respected leader. I am also looking forward to continuing to working alongside her to deliver our strategy."

 

Kevin O'Byrne, Chief Financial Officer, said:

"It has been a real privilege to work with all my colleagues in Sainsbury's. I am very pleased to be handing over to Bláthnaid who will bring great commercial drive to the role. I shall continue to focus, with my team, on delivering our plan and driving momentum while managing a smooth transition over the next nine months."

 

Bláthnaid Bergin said:

"Kevin has been an excellent mentor over the last few years and I wish him well in the future. I am looking forward to joining the Board and supporting Simon's vision in driving value for our customers and stakeholders."

 

There are no additional matters that would require disclosure under LR 9.6.13R (1).

 

Contacts:

 

Investor Relations: James Collins +44 (0) 20 7695 0080

 

Media: Rebecca Reilly +44 (0) 20 7695 7295

 

 

Notes:

 

All remuneration arrangements for Kevin O'Byrne's departure are consistent with the Company's shareholder approved remuneration policy and the Company's incentive plan rules. 

 

Kevin O'Byrne will receive base salary, pension and benefits through to his retirement on 4th March 2023. He will be considered for an annual bonus for 2022/23 based on financial and strategic objectives. Any award will be 50% in cash and 50% in shares subject to a two-year deferral period. 

 

In light of his contribution to the business and his planned retirement, Kevin will be treated as a good leaver for all of his outstanding deferred bonus shares and LTIP share awards. These will be released on the scheduled vesting dates and, in respect of the LTIP grants, to the extent performance conditions are met and after pro-rating for the portion of the performance period worked. Post vesting holding periods, where relevant, and malus and clawback terms apply. A post-employment shareholding requirement of 200% of salary applies for two years after departure.

 

Other than as detailed above, Kevin will not receive any other compensation or payment related to the termination of his employment.

 

Bláthnaid Bergin's remuneration will be in line with the shareholder approved remuneration policy. Further detail will be disclosed on her appointment to the Board in March 2023.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFVLDTISIIF
Date   Source Headline
3rd Jul 20264:00 pmRNSDirector Declaration
3rd Jul 20263:15 pmRNSDirector/PDMR Shareholding
3rd Jul 20267:00 amRNSTransaction in Own Shares
2nd Jul 20264:00 pmRNSResult of AGM
30th Jun 20264:25 pmRNSTotal Voting Rights
30th Jun 20267:00 amRNSTrading Statement
26th Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 202610:00 amRNSHolding(s) in Company
12th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20262:00 pmRNSDirector/PDMR Shareholding
5th Jun 20263:30 pmRNSDirector/PDMR Shareholding
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20263:00 pmRNSHolding(s) in Company
2nd Jun 20263:04 pmRNSAnnual Report and Notice of AGM 2026
1st Jun 20262:00 pmRNSDirector/PDMR Shareholding
1st Jun 20261:00 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
8th May 20263:30 pmRNSDirector/PDMR Shareholding
8th May 20267:00 amRNSTransaction in Own Shares
1st May 20262:30 pmRNSDirector/PDMR Shareholding
1st May 20261:00 pmRNSTotal Voting Rights
1st May 202610:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20263:15 pmRNSDirector/PDMR Shareholding
27th Apr 20262:00 pmRNSPresentation via Investor Meet Company
24th Apr 20264:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSCommencement of Share Buyback Programme
23rd Apr 20267:00 amRNSPreliminary Results
10th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 20263:50 pmRNSTotal Voting Rights
1st Apr 20262:30 pmRNSHolding(s) in Company
13th Mar 20263:30 pmRNSDirector/PDMR Shareholding
10th Mar 20263:30 pmRNSHolding(s) in Company
10th Mar 20263:30 pmRNSHolding(s) in Company
5th Mar 20263:00 pmRNSAdditional Listing
2nd Mar 20261:00 pmRNSTotal Voting Rights
13th Feb 20263:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:20 pmRNSTotal Voting Rights
23rd Jan 20262:15 pmRNSEMTN Programme Publication of Base Prospectus
20th Jan 20267:00 amRNSTransaction in Own Shares and Programme Completion
19th Jan 20263:25 pmRNSBlock listing Interim Review
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20262:30 pmRNSDirector/PDMR Shareholding
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20262:00 pmRNSDirector/PDMR Shareholding
14th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.